{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "BAK",
  "name": "Braskem S.A.",
  "url": "https://frontierpicks.com/dossiers/BAK/",
  "json_url": "https://frontierpicks.com/dossiers/BAK.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a5",
    "n": 5
  },
  "current_thesis": "Q2 2026 (released 2026-08-14) printed US$1.043B recurring EBITDA on a Middle East supply shock management called tactical — and the ADR closed $1.95, pricing the capital structure rather than the P&L. The 2026-06-26 São Paulo shield expires 2026-08-24 with the extrajudicial plan still unfiled; equity-impairment tail is live.",
  "invalidation_trigger": "A weekly close below $1.80 takes out the August low zone and the $1.83 floor cited on the unadjusted ADR, confirming equity impairment is being priced; secondary condition: 2026-08-24 passing with no extrajudicial filing and no injunction extension, or a judicial reorganization petition instead.",
  "catalyst_date": "2026-08-24",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "biofuels-low-carbon",
    "emerging-markets",
    "m-and-a-special-situations"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "BAK is a NYSE-listed ADR over Braskem class A preferred shares (BRKM5 on B3); Brazilian-tape moves and BRL/USD pass through to the ADR.",
    "Chapter 15 recognition was filed in the Southern District of New York on 2026-06-26; US creditor actions run through that docket.",
    "Voting control sits with IG4 Capital (~50.1% via the Shine I fund) and Petrobras (~47%); ADR holders do not decide the restructuring outcome.",
    "Alagoas geological-event provisions stood at R$3.2B at Q2 2026, split 32% current / 68% non-current — a cash claim alongside the financial debt.",
    "As a foreign private issuer Braskem reports via 6-K and 20-F, not 10-Q; quarterly detail arrives in the results release and presentation."
  ],
  "body_markdown": "## Current Thesis\nThe operating result and the security have decoupled. Braskem released Q2 2026 on 2026-08-14: recurring EBITDA of US$1.043B at a 24.2% margin, more than five times Q1 2026's US$192M, with net income of US$664M — and the ADR fell 5.56% on the day to close at $1.95 on the pipeline's adjusted series. Management framed the quarter as \"tactical capture of value in a volatile environment, not as a structural change in the cycle,\" pointing to Middle East supply disruption and guiding spreads to normalize through H2 2026 and 2027. What prices the equity is the 60-day São Paulo precautionary injunction granted 2026-06-26, which expires **2026-08-24**, and whether the extrajudicial reorganization (recuperação extrajudicial) covering more than US$10B of debt is filed with creditor support before then. Reuters reported on 2026-08-12 that talks were advanced and a filing could come inside August, structured around a 90-day stay. The narrative leg an investor would be buying is recovery value on a plan that leaves the common intact, plus a 2027 up-cycle option — not a momentum theme.\n\n## Bull Case\n- **Q2 2026 proved the asset base can print (2026-08-14).** Recurring EBITDA US$1.043B, 24.2% margin; Brazil US$869M (+261% QoQ), US and Europe US$147M. An operating platform capable of a billion-dollar quarter is a different negotiating object than a melting one.\n- **Capex discipline is real.** The 2026 budget is US$485M with only ~35% spent through H1 2026, and Q2 interest paid was US$136M against ~US$210M of recurring quarterly cash generation after US$547M of working-capital consumption.\n- **An extrajudicial route preserves more equity optionality than a court-run reorganization.** The reported structure carries a 90-day stay while a plan is negotiated; a deal approved by a judge rather than administered by one is the path in which the common is least likely to be extinguished.\n- **Two controlling holders with reasons to defend residual value.** IG4 Capital holds ~50.1% of voting capital via the Shine I fund and Petrobras ~47% of voting rights.\n\n## Bear Case\n- **The prior bear-confirm level registered.** The 2026-07-26 coverage flagged a weekly close below $2.00 as confirmation the market was pricing equity impairment; the 2026-08-14 close of $1.95 delivered it, with the 3-month return at -60.2%.\n- **Revenue missed while EBITDA surged.** Q2 net revenue of US$4.31B came in under the US$4.67B consensus — the beat was spread-driven and management has already told holders it reverses.\n- **The August deadline is hard.** If no deal is in place by 2026-08-24, enforcement protection lapses and a formal court-run restructuring becomes the live path. The opening term sheet — five-year extension, unsecured status retained, 100% PIK from July 2026 through December 2028, then +200bps — was rejected by creditors demanding shareholder burden-sharing and a Petrobras injection that has not been forthcoming.\n- **A second restructuring track is open.** Braskem Idesa's ~US$2B of Mexican debt is under review with a possible Chapter 11, on a timeline roughly aligned to the Brazilian process.\n- **Chapter 15 recognition (SDNY, filed 2026-06-26) and the 2026-06-30 rating actions — Fitch to C, S&P into default territory — describe the parent, not a subsidiary.**\n\n## Setup & Price Structure\nReference close 2026-08-14: $1.95, -61.2% from the 52-week high of $5.02 on the split/dividend-adjusted series; RSI(14) 25.3. Investing.com cited an unadjusted ADR 52-week range of $1.83–$5.40 in its 2026-08-14 earnings coverage, putting the print-day close within roughly 7% of the low end of that range. There is no base: the $2.00 shelf that held through late July broke in the week of the Q2 release, and price is making lows into the 2026-08-24 expiry. Oversold readings inside a restructuring are a function of where the capital structure settles.\n\n**The narrative is dead.** The dating is specific — the equity narrative broke on 2026-06-26 (injunction plus Chapter 15) and 2026-06-30 (Fitch C, S&P default), and the 2026-08-14 tape rejected the strongest operating quarter in years. Coverage is now credit-desk and Brazilian business press (Reuters 2026-08-12, InfoMoney and Money Times 2026-08-13) rather than equity-momentum flow.\n\n**Crowding and positioning observables:** no retail-sentiment clustering is visible in the coverage — the flow is distressed-debt reporting; the earnings binary is behind, not ahead (Q2 released 2026-08-14); price sits roughly 61% below the adjusted 52-week high with no rising moving average to be extended above; the Street's average 12-month target was reported near $1.50 following JPMorgan's 2026-06-30 downgrade on restructuring risk, i.e. below the last close. Dilution risk here would arrive as a plan term, and none has been filed.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-09 (est.)** — Braskem Idesa restructuring decision on ~US$2B, Chapter 11 among the options.\n\n## Elapsed catalysts\n\n- **2026-08-24** — 60-day precautionary injunction from the 2nd Bankruptcy and Restructuring Court of São Paulo (granted 2026-06-26) expires. *(passed 2d ago)*\n- **~2026-08-24 (est.)** — potential extrajudicial recovery filing; Reuters 2026-08-12 reported advanced creditor talks and a 90-day stay structure covering >US$10B of debt in Brazil, the US and Europe. *(passed 2d ago)*\n\n## What Would Change Our Mind\nThe structure that matters is legal, and it breaks in two directions. Bear-confirming: 2026-08-24 passing with no extrajudicial filing and no extension, an RJ (full judicial reorganization) petition instead, or a filed plan carrying debt-for-equity conversion — any of which prices the common as a stub. The gradeable version is a weekly close below $1.80, which takes out the August low zone and the $1.83 floor cited on the unadjusted ADR. Bull-confirming, and the only condition under which the distressed read stops holding: a filed and creditor-supported plan that extends maturities without converting debt to equity, alongside a reclaim of the $3.00–$3.30 shelf on expanding volume.\n\n## Correlation Notes\nDay-to-day, the ADR tracks the B3-listed preferred line and BRL/USD more than the US petrochemical complex. Fundamentals key off polyolefin spreads — the Q2 2026 surge came from a Middle East supply shock that management expects to unwind — plus naphtha and US ethane feedstock costs, which links the operating result loosely to LYB, DOW and WLK spread commentary. Petrobras is both a ~47% voting holder and a repeatedly floated rescuer, so PBR headlines carry event risk into this name. Broader EM-Brazil beta (EWZ) is a secondary driver; from here, the court docket dominates all of it.",
  "first_seen": "2026-05-20",
  "last_analyzed": "2026-08-16T14:20:02+00:00",
  "last_synthesized": "2026-08-16",
  "last_update_source": "watchlist_research",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}